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Abstract
Background: The aim was to ascertain whether thrombocyte MAO (trbc-MAO) activity and
depressed state are genetically associated with the MAO locus on chromosome X (Xp11.3 – 11.4).
We performed novel sequencing of the MAO locus and validated genetic variants found in public
databases prior to constructing haplotypes of the MAO locus in a Swedish sample (N = 573
individuals).
Results: Our results reveal a profound SNP desert in the MAOB gene. Both the MAOA and MAOB
genes segregate as two distinct LD blocks. We found a significant association between two MAOA
gene haplotypes and reduced trbc-MAO activity, but no association with depressed state.
Conclusion: The MAO locus seems to have an effect on trbc-MAO activity in the study
population. The findings suggest incomplete X-chromosome inactivation at this locus. It is plausible
that a gene-dosage effect can provide some insight into the greater prevalence of depressed state
in females than males.
Background
Monoamine oxidase A (MAOA) and B (MAOB) are
enzymes that deaminate monoamines such as serotonin,
dopamine and noradrenaline. The genes encoding MAOA
and B are located on the X chromosome in a tail-to-tail
orientation and separated by approximately 20 kilobases
(kb) [1,2]. Although MAOA and MAOB span 65 kb and
116 kb, respectively, both genes display a high degree of
homology and most certainly have a common ancestry
[3]. The frequencies of confirmed polymorphisms in the
two genes vary widely among different ethnic groups [4-
6]. Only two common haplotype variants of the MAOA
locus were found among individuals of northern Euro-
pean ancestry [5].
Both enzymes are localized in the outer mitochondrial
membrane [7]. They are also present in glial cells [8],
although MAOA is less expressed than MAOB [9]. The
enzymes differ in their expression patterns not only
peripherally in the body but also in the central nervous
system (CNS) [10]. MAOB is the only form that is
expressed in human blood cells. MAOA is primarily
expressed in catecholaminergic neurons in the human
brain [10,11], whereas MAOB is expressed in serotonergic
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enzymes also differ on substrate preferences; MAOA pref-
erentially metabolizes serotonin and norepinephrine
while MAOB has a much higher affinity for phenylethyl-
amine [12,13] and benzylamine [14].
Thrombocyte-MAO activity (Trbc-MAO) has been associ-
ated with cerebrospinal fluid (CSF) levels of serotonin
metabolites in humans [15] and is higher in women than
men [16-18]. This difference has been speculated to be an
effect of sex steroids altering the enzyme's activity or a
matter of escaped X-inactivation [19]. The proportion of
variance in trbc-MAO activity explained by genetic factors
(its heritability) in a Swedish population is 77% [20].
Trbc-MAO activity is weakly associated with a C/T poly-
morphism in intron 13 of the MAOB gene in a Swedish
population [21] and is also influenced by smoking and
specific medications; smokers can have a 30–40% lower
trbc-MAO activity than non-smokers [22]. Trbc-MAO
activity is also associated with several psychiatric syn-
dromes [23], personality traits and mood disorders e.g.
[24-28].
In the present study we address issues concerning genetic
variation in MAOA and MAOB genes, activity levels of
trbc-MAO, and associations with depressed state. Genetic
variation was analyzed by sequencing the regulatory
region of both MAOA and MAOB, and validating SNPs
reported in public databases. We used multiple SNPs cov-
ering the MAO gene locus to generate haplotypes on a
population level. Finally, we investigated associations
between depressed state and trbc-MAO activity and
genetic variants in the MAO locus in a large elderly Swed-
ish population.
Results
Trbc-MAO activity and depressed state
We found a clearly significant difference between males
(mean; 10.7) and females (mean; 12.1) (t = 4.69; p ≤
0,0001), as well as between smokers and non-smokers in
mean trbc-MAO activity (t = 5,86; p =< 0,0001). Smokers
showed a 23% lower trbc-MAO activity compared to non-
smokers. Females with a depressed state showed a signifi-
cantly higher mean trbc-MAO activity than unaffected
females (t = 2,02; p = 0,04).
Genetic variants and haplotype construction
Approximately 4.5 kb of both the MAOA and MAOB gene
promotor, including the first exons, totaling 9 kb, were
sequenced from a total of 148 X chromosomes. Power to
discover SNPs with frequencies greater than 1% and 3%
for this sample size was 77% and 100%, respectively. No
variants were found in the MAOB gene. In contrast, one
previously reported variation was confirmed (rs3788863)
for the MAOA gene, lying within the first intron, as well as
two additional variants further down stream with a minor
allele frequency greater than 1%. Both the recorded and
most distal variants showed complete LD with each other,
therefore only the recorded variant was chosen for further
analysis.
The genotyping error rate was calculated at 0,4% through
males scoring as heterozygotes and from MZ twins where
both twins in a pair were genotyped. These errors could
not be scored differently from the sequence and therefore
most likely reside in the handling of samples, e.g. contam-
ination or labelling error.
In addition to resequencing the upstream regions, we gen-
otyped reported SNPs in the remainder of the gene clus-
ters by Pyrosequencing. Six of the previously reported
SNPs could not be confirmed as polymorphic
(rs1014876, rs3027464, rs6324, rs1040398 and two SNPs
reported by Balciuniene et al.) The remaining nine poly-
morphic variants; one in the Norrie gene (rs766117), four
SNPs in MAOB (rs1181252, rs2283729, rs3027452 and
rs1799836) and four SNPs in MAOA (rs1801291,
rs979605, rs6323, rs388863) were sequenced in the total
sample.
The LD map (Figure 2) displays a clear structure of the
MAO locus with strong LD across the MAOA gene in a dis-
tinct block spanning approximately 65 kb. The MAOB
gene also displays a similar block-like structure, although
the pattern of LD is not as robust as for MAOA. This is per-
haps due to the inconsistencies in allele frequencies across
MAOB. Interestingly, weak LD is observed at the tail ends
between the two MAO loci.
Furthermore, because there was no LD between the Norrie
gene variant, located >66 kb upstream of MAOB, and any
other variant in the MAO region, we decided not use this
variant further in the haplotype assessment. Modest devi-
ations from Hardy-Weinberg equilibrium were noted in
rs766117 in the Norrie gene (p = 0,022) and rs979605 in
intron 10 of the MAOA gene (p = 0,028). This could reflect
the underlying LD structure [29], as demographic influ-
ences would act over larger regions [30]. However to clar-
ify this, a denser set of SNPs would need to be genotyped.
In the male population we could identify five distinct hap-
lotypes in the MAOB gene and four in the MAOA gene
with frequencies ≥1% (Figure 1.). When analyzing the
MAO locus as one large block using eight SNPs, we found
ten distinct locus haplotypes with a frequencies ≥1% (data
not shown). In the female population, "PHASE" assem-
bled identical higher frequency haplotypes as were identi-
fied in the male sample, with minor discrepancies in
lower frequency haplotypes due to unknown phase (Fig-
ure 1).Page 2 of 9
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In the total sample, no single variant of any of the individ-
ual SNPs was associated with trbc-MAO activity. However,
in females the C/C and C/T genotypes of rs979605 in the
MAOA gene were associated with a significant decrease in
trbc-MAO activity, (-2,9; CI 95%: -5,2 – -0,6) and (-2,4; CI
95%: -4,7 – -0,1) respectively.
Analyzed by gender, depressed state was associated with
the A-allele of MAOB SNP rs1181252 in males (OR = 4,5;
CI 95%: 1,0 – 21,7) and both GG and GA of rs766117
(OR = 2,2; CI 95%: 1,1 – 4,3) in females. It should be
noted that the "A" allele of rs1181252 only had a popula-
tion frequency of 6%.
Associations with haplotypes
There was no association between any of the MAOB hap-
lotypes and trbc-MAO activity. Two MAOA haplotypes, A1
and A3, both sharing identical alleles at the three first hap-
lotype positions (CCA-) (Figure 1), were associated with a
significant decrease in trbc-MAO activity (Table 1). Analy-
ses of the entire MAO locus and trbc-MAO activity did not
reveal any significant findings (data not shown). We
could not find any significant associations between
depressed state and any specific haplotype in men or
women (Table 2).
When the model was analyzed without genetic informa-
tion, males have a significantly lower risk for being
affected with depressed state compared to women (OR =
0,5). This gender effect may be explained by the genetic
information (even though no associations were found
with any of the haplotypes), because the risk for depressed
state due to the male gender is differs in the analyses of the
MAOA locus (OR = 1,4; non-significant) and the MAOB
locus, where the estimate is similar to the model without
genetic information.
Interestingly, in females all MAOB homozygote haplo-
types displayed greater odds ratios with depressed state
than that for heterozygotes (Table 2), indicating an addi-
tive effect. The same was true for MAOA (Table 2).
Genetic structure of the MAO locusFigure 1
Genetic structure of the MAO locus. Haplotype and common allele frequencies in the total sample. dbSNP rs numbers for 
all genotyped SNPs are presented with major allele frequencies. Haplotypes frequencies illustrated for MAOA and B separately 
as well as the genes combined (See Text). NDP was not used in the haplotype frequency estimations.Page 3 of 9
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Monoamine oxidase A and B constitute two important
molecules in the human body in general and in the
central nervous system (CNS) in particular. Numerous
studies suggest a contribution of these two mitochondrial
enzymes to complex human behaviors [26-28,31-33]. In
the present study we searched the MAO locus for novel
genetic variants and evaluated the genetic and haplotype
structure in a Swedish population. We also assessed asso-
ciations between trbc-MAO activity and depressed state,
and their respective associations with the genetic structure
of the MAO locus. The key findings of this study are first:
the profound lack of variation at functional regions of the
two MAO genes and a pattern of two distinct genetic LD
blocks, one for each gene. Second: we replicated the gen-
der differences in trbc-MAO activity and demonstrated an
association between trbc-MAO activity and depressed
state in women. Third: two MAOA haplotype variants
were associated with decreased trbc-MAO activity
although we could not replicate a previously reported
genetic association between the MAOB gene and trbc-
MAO activity. Fourth: we could not find any significant
associations between the genetic variants and depressed
state. On the other hand, there was an interesting,
although not significant dose-response effect of haplo-
types displayed in women, with greater odds ratios in
homozygotes than heterozygotes.
Considering the size and importance of the MAO locus,
relatively few polymorphic sites have been verified. We
observed two new variants through sequence screening a
partial region of MAOA intron 1, but in MAOB neither the
previously reported nor any novel variants were found in
the areas sequenced. It is surprising that so few SNPs were
discovered given our power to detect variants with very
low frequencies. SNP deserts have been previously noted
on the q arm of the X chromosome [34]. Gilad and col-
leagues [4] have described similar features across MAOA,
where extensive LD and low nucleotide diversity suggest
recent action by population structure forces and perhaps a
recent positive selection sweep [35]. Although we could
not evaluate the influence of such forces, evidence of
strong LD and the lack of decay across MAOA in our Swed-
ish sample complement these previous findings. Linkage
disequilibrium decays rapidly between the two MAO
genes (separated by approximately 20 kb). Perhaps selec-
LD mapFigure 2
LD map. Pair-wise LD map with one individual from each female pair (N = 356). D' is shown below the diagonal and ∆2 above 
the diagonal. Color code D': Red: ≥0,8 Orange: 0,5–0,8 Yellow: 0,3–0,5 White: <0,3. Color code ∆2: Red: ≥0,30 Orange: 0,1–
0,30 Yellow: 0,05–0,1 White: <0,05.Page 4 of 9
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expected in each MAO gene, both separated by regions of
higher recombination than that within each gene.
Previous studies have indicated that the MAOA gene may
harbour relatively few haplotypes within a block structure
[5]. We observed similar results here with two haplotypes
encompassing 95% of the haplotypic variation. We found
similar results for the MAOB gene, with a distinct block
structure in which three haplotypes explain 93% of the
variation. So few haplotypes over such long distances
have been observed previously (McCarthy et al, manu-
script) and are proposed signatures of selection and pop-
ulation substructure on the X chromosome [36,37].
A previous Swedish association between the MAOB gene
and trbc-MAO activity [21] could not be replicated nor
distinctly refuted, as we found a small non-significant
effect of the same allele in males. However, none of the
haplotype blocks carrying this allele could strengthen or
support this effect, suggesting that this allele is not in high
LD with a larger region of the MAOB gene.
Two MAOA haplotypes (A1 and A3) showed a significant
association with reduced trbc-MAO activity. Both haplo-
types shared the initial sequence variants [CCA], but var-
ied at the fourth allele [T/C]. Given that only MAOB is
expressed in platelets there is no clear explanation for this
finding. Given the minor kinetic differences between
platelet and brain MAO-B [38] and the correlation of
MAOB and MAOA levels in regions of the brain [39], this
association may reflect MAOA activity in the brain. On the
other hand, it is possible that the MAOA locus holds cis-
acting regulatory elements affecting MAOB expression.
Another possible explanation could be that one or several
single-base variants affected by methylation cause
changes in the expression pattern [40].
Our study is based on a relatively large population-based
sample of normally aging adults, although it is not with-
out its limitations. We have controlled for smoking, but
were unable to do so for intake of certain medications.
The study sample was included in a larger study where
associations between depressed state and the serotonin
receptor 2A and the serotonin transporter were evaluated
[41]. The influence of these genes has not been corrected
for in the analysis.
Conclusion
Good et al [19] demonstrated that trbc-MAO activity is
related to the number of X chromosomes. We replicated a
significant difference in trbc-MAO activity between males
and females reported by others e.g. [17]. The findings sug-
gest incomplete X chromosome inactivation at this locus
and are consistent with other findings of genes escaping
inactivation on the X chromosome [42,43]. It has been
hypothesized that this dosage imbalance between males
and females might be crucial for gender characteristics
[19,44]. Recently it was demonstrated that a number of
genes, including MAOA, escape X-inactivation [45]. Fur-
thermore, the X-inactivation pattern, which shows a sub-
stantial heritability [46], increases in the elderly. Although
we could not find a significant association between vari-
ants of MAOB or MAOA and depressed state in this popu-
Table 1: Associations between MAO haplotypes and trbc-MAO activity, reported as unit change in mean trbc-MAO activity per allele 
and controlling for gender and smoking status.
Total sample N = 340 Males N = 156 Females N = 184
per allele Hemizygous per allele
Haplotypes Estimates (Unit change in mean trbc-MAO activity per allele)
B1 -0,38 (-1,3 – 0,5) 0 (ref) -0,3 (-1,1 – 0,5)
B2 -0,63 (-1,8 – 0,5) -0,08 (-1,6 – 1,5) -0,4 (-1,5 – 0,7)
B3 -0,18 (-1,6 – 1,3) -0,8 (-2,9 – 1,2) -0,2 (-1,5 – 1,0)
B4 -1,3 (-3,5 – 0,8) 0,7 (-2,8 – 4,3) -1,0 (-2,8 – 0,8)
B5 -1,7 (-5,1 – 1,6) NA -0,7 (-3,8 – 2,4)
Male gender -2,1 (-3,3 – -0,9)*
Non-smokers 2,3 (1,1 – 3,5)* 1,5 (0,2 – 2,8) 3,5 (2,0 – 5,0)
A1 -1,1 (-1,9 – -0,3)* -1,8 (-3,2 – -0,5)* -1,0 (-1,7 – -0,3)*
A2 0,1 (-0,9 – 1,2) 0 (ref) 0,6 (-0,4 – 1,5)
A3 -3,1 (-6,1 – -0,14)* -2,3 (-5,8 – 1,2) -4,1 (-7,4 – -0,7)*
A4 -0,02 (-3,8 – 3,7) NA -0,5 (-3,7 – 2,7)
Male gender -2,3 (-3,5 – -1,1)*
Non-smokers 2,4 (1,1 – 3,6)* 1,4 (0,03 – 2,8) 3,4 (1,9 – 4,8)Page 5 of 9
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women, with a higher risk for depressed state with
homozygosity. Whether levels of trbc-MAO activity are
correlated with the number of X chromosomes and
whether this might be linked to the higher prevalence of
depressive symptoms in females deserves further investi-
gation. Nevertheless it is plausible that a partially doubled
gene activity on the X chromosome can explain difference
in prevalence of depressive state in men and women.
Methods
Participants
The participants were taken from a longitudinal twin
study of aging, the Swedish Adoption/Twin Study of
Aging (SATSA) with up to five occasions of measurement
[47]. SATSA is a sub-sample of the population based
Swedish Twin Registry [48]. All participants are Caucasian
and born in Sweden. For the present analyses we selected
all individuals who participated in an in-person testing
session during which questionnaires were administered
and a blood sample was drawn. The mean age of the sam-
ple was 61,3 years at the time of testing. Twenty two per-
cent of the participants were current smokers; 35% of the
males and 15% of the females.
Zygosity was initially based on self-reports of similarity
and confirmed by serological analyses and comparisons
of up to 10 DNA markers.
For preliminary screening of the promoter, the first exon
and intron regions for novel variants, 94 Swedish male
blood donors were randomly selected from a larger sam-
ple set collected to study MAOB regulation. All were
between the ages of 20 to 40 years and non-smokers.
This study was reviewed and approved by the Ethics Com-
mittee of the Karolinska Institute, the Swedish Data
Inspection Board, and the IRBs at the University of South-
ern California and the Pennsylvania State University. All
subjects provided informed consent.
DNA and trbc-MAO activity
DNA samples were available from 573 twins. Trbc-MAO
activity measures were available from 565 twins. The trbc-
MAO activity is expressed as nmoles of 2-phenylethyl-
amine oxidized per minute and per 1010 platelets. Trbc-
MAO activity measures have previously been described in
detail [20].
Depressed state
Depressive symptoms were measured with the Center for
Epidemiologic Studies Depression Scale (CES-D), a 20-
item self-report instrument developed for use in the com-
munity and well established for use with older adults
[49,50]. The scale has been shown to have minimal over-
lap with physical illness [51] and assesses current symp-
toms during the past week. Respondents scoring 16 or
higher on the CES-D scale are considered to have a clini-
cally relevant depressed state. In this study population of
574 participants, 144 were classified as having a depressed
state, 17.9% of the males and 30.2% of females.
Table 2: MAO haplotypes and depressive state, reported as odds ratios per allele. Without genetic information in the model male 
gender was significant [OR: 0,5 (0,3 – 0,8)] for depressive state. *Homozygote compared to heterozygote.
MAO haplotypes and depressive state
Total sample N = 573 Males N = 239 Females N = 334
per allele Hemizygous per allele Homozygotes*
Odds Ratio with 95% CI
B1 1,2 (0,6 – 2,5) 1,0 (ref) 1,4 (0,6 – 2,9) 1,3 p = 0,57
B2 1,5 (0,7 – 3,3) 1,7 (0,8 – 3,6) 1,5 (0,6 – 3,3) 1,2 p = 0,80
B3 1,3 (0,5 – 3,0) 0,7 (0,3 – 1,7) 1,7 (0,7 – 4,2) 1,9 p = 0,51
B4 2,0 (0,8 – 5,2) 3,7 (0,7 – 18,7) 2,0 (0,7 – 5,3) 1,7 p = 0,59
B5 0,5 (0,1 – 2,8) 2,4 (0,4 – 14,5) 0,3 (0,04 – 2,5) NA
Male gender 0,7 (0,3 – 1,5)
A1 3,0 (0,8 – 12,2) 1,0 (ref) 2,2 (0,6 – 8,4) 5,5 p = 0,08
A2 2,5 (0,6 – 10,6) 0,9 (0,4 – 1,8) 1,7 (0,4 – 7,1) 1,3 p = 0,80
A3 2,8 (0,7 – 11,4) 1,2 (0,3 – 4,4) 1,7 (0,4 – 6,9) NA
A4 3,2 (0,6 – 18,6) NA 2,8 (0,4 – 17,3) NA
Male gender 1,4 (0,3 – 6,0)Page 6 of 9
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Approximately 4.5 kb of each gene was initially sequenced
in search of novel SNPs in both MAOA and MAOB, first in
94 Swedish males and later 45 twins with CES-D scores
(36 males and 9 females). Power to detect minor allele fre-
quencies (q) between 1 and 5% was determined as by
Glatt et al. [52], 1-(1-q)N where N is the number of chro-
mosomes. Amplification and nested sequencing primers
were designed with the CPrimers programme from Gen-
bank entry GI:8671203 containing the promoter, coding
exon 1 and flanking intronic sequence of MAOA (~5.0 kb,
nucleotides 46490–51454) and Genbank entry
GI:2440066 spanning the same characterized sequences
of MAOB (~4 kb nucleotides 35033–39021).
Direct sequencing reactions were performed using
DYEnamic ET Dye Terminator Cycle Sequencing Kit
(Amersham Biosciences) and separated using a Megabace
1000. Reads were base called with Phred [53], assembled
using Phrap and viewed using Consed Version 13 [54]. All
SNPs were documented and cross validated with dbSNP at
NCBI.
Twelve SNPs identified from public databases (dbSNP at
NCBI) and two novel SNPs previously reported (introns 3
and 10 of MAOB) a Swedish sample [5] were sequenced
in 95 participants (142 chromosomes) by Pyrosequencing
to confirm their presence in this population. For Pyrose-
quencing, either the forward or the reverse primer in each
primer pair was biotinylated. Sequencing primers with a
length of 14 and 18 bases were placed within one base of
the SNP. The PCR reaction was performed in a 50 µl reac-
tion volume, containing 5 ng of genomic DNA, 10 pmoles
of each primer, 0.2 mM of each dNTP, 1.5 mM MgCl2 and
1.5 U of Taq. Thermal cycling was performed in a PTC-225
DNA machine (MJ Research Inc., Cambridge, MA, USA) at
95°C for 5 min followed by 50 cycles of 95°C for 30 s, 45
s of annealing at an optimized temperature, followed by
72°C for 30 s and a final extension of 5 min at 72°C. The
biotinylated PCR product was immobilized onto strepta-
vidin-coated sepharose beads and DNA strands were sep-
arated by denaturation with 0.2 M NaOH. The
pyrosequencing reaction was performed on a PSQ96™
Instrument from Pyrosequencing AB (Uppsala, Sweden)
as described by [55,56]. Detailed primer and assay infor-
mation are available upon request.
Statistical analysis
Male haplotypes could be extrapolated directly since the
MAO locus is located on the X chromosome and males are
thereby hemizygous. Female bi-allelic haplotypes were
estimated using an EM algorithm (Sham 1998) and the
pair-wise LD measures D' [57] and ∆2 [58]. We used
"PHARE" (by David G Cox, available at http://bioinfor
matics.org/macroshack/programs/PHARE) to create input
files for "PHASE" [59,60] to construct female haplotypes.
We used linear regression to estimate the association
between trbc-MAO activity and genotypic information
using a generalized estimating equation (GEE) approach
and alternating logistic regression (ALR) [61] to estimate
the association between depressed state and genotypic
information. We first modeled the association between
single SNPs and each of the two outcomes and then mod-
eled the association between haplotype constructs and the
two outcomes. All estimates were adjusted for current
smoking status. We estimated both dominance and co-
dominance models. Explanatory variables in the domi-
nance models were binary whereas in the co-dominance
models they were coded as the number of reference alleles
(i.e., 0, 1, or 2 for females and 0 or 1 for males). The
parameter estimates for the co-dominance models repre-
sent the change in the outcome (trbc-MAO activity or
odds of being in a depressed state) per affected allele. Due
to the continuous nature of the trbc-MAO measure, only
one individual from each complete twin pair and single
participating individuals were analyzed (N = 340).
Among females we also estimated the effect of being
homozygote compared to heterozygote. If the co-domi-
nance model is a good fit to the data then these estimates
should be similar to the "per allele" estimates from the co-
dominance model. All statistical analyses were performed
in SAS 8.01 using GENMOD procedure (SAS Institute Inc.
Cary, NC).
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